Life Expectancy with Diabetes — and Without: The Sharpest Numbers Yet

The study, a PRISMA-guided systematic review and meta-analysis published in Frontiers in Endocrinology, pooled 23 studies and 179 cohorts — more than 65,000 people with type 1 diabetes (T1D) and over 139 million with type 2 diabetes (T2D) — to estimate average life expectancy across groups. It's the most comprehensive benchmark we have so far, and it gives metabolic health a clearer place in the longevity conversation: a central one, but not a deterministic one. The researchers used random-effects models, reported wide prediction intervals, and were transparent about heterogeneity, which is the polite scientific way of saying: these are averages drawn from very different populations, and your individual story is not a line on this graph.

Here is what they found, in plain numbers. Average life expectancy was shortest among adults with T1D — roughly 65.1 years in men and 68.3 years in women. For T2D, the pooled estimate was 74.3 years in men, with the women's figure in the same broad range. Those numbers sit below typical non-diabetic life expectancy in the same cohorts, which is the gap the authors set out to quantify as years of potential life lost. The differences are real and meaningful — but the prediction intervals are wide (the T1D men's interval, for instance, stretched from the early 40s into the late 80s), which tells us care, context and era matter enormously.

Diabetes shortens average life expectancy mainly through its downstream effects: cardiovascular disease, kidney disease, and the slow erosion of small blood vessels that supply nerves, eyes and organs. The mechanism, simply put, is that chronically elevated blood glucose and the insulin-handling problems behind it stress the vascular system over decades. The newer the cohort and the better the care, generally, the smaller the gap — which is part of why the authors did meta-regression on cohort year. The body of evidence here is solid in design but moderate in certainty: averages from observational cohorts, not a controlled experiment on your future.

For parents reading this on four hours of sleep, the takeaway isn't a personalised prognosis. It's a frame. Metabolic health — how your body manages glucose, fat, blood pressure and weight over years — is one of the biggest modifiable inputs to how long, and how well, you live. That's a reason for attention, not alarm.

If you have diabetes, or a family history, or a recent borderline lab result, the honest read is this: the gap exists, and it is also narrower than it used to be in many settings. The meta-analysis was designed to compare across regions and eras, and the authors' decision to publish prediction intervals — not just confidence intervals — is a quiet act of intellectual honesty. It says: on average, here is the picture; for any one person, the range is wide, and what fills it includes things like blood pressure control, kidney function, smoking, sleep, movement and access to care.

None of that is a prescription. A clinician who knows your history is the right person for that conversation, especially if you're pregnant, postpartum, or managing T1D or T2D alongside a young family. What an article like this can offer is perspective: the smallest useful step usually beats the perfect plan you can't start this week.

What I find quietly hopeful about this paper is not the averages themselves but the structure beneath them. The fact that newer cohorts tend to do better suggests that the gap is responsive — to medication, to monitoring, to the unglamorous daily levers of sleep, movement and food. None of that is news. But having a clearer number to push against makes the work feel less abstract, especially when the work in question is fitting a walk in between nap time and dinner.

The headline isn't that diabetes steals a fixed number of years. It's that metabolic health is worth paying attention to early, gently and consistently — and that the science is finally catching up to tell us, with reasonable confidence, just how much that attention may be worth.